Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01921192` - Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy	Phase 4
Recruiting	`NCT01044875` - Trial of Yellow 577 nm Laser Versus Green 532 nm Laser for Proliferative Diabetic Retinopathy	N/A
Active, not recruiting	`NCT00993525` - Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)	Phase 1/Phase 2
Completed	`NCT01307072` - Compliance to Ophthalmic Follow-up Examinations and Surgical Outcome for Proliferative Diabetic Retinopathy	N/A
Completed	`NCT01758757` - Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy	N/A
Withdrawn	`NCT00600236` - HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population	Phase 3
Completed	`NCT05414149` - Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy	N/A
Completed	`NCT05408416` - Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR	N/A
Not yet recruiting	`NCT04464694` - Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema	Phase 4
Completed	`NCT03490318` - Effectiveness of Multimodal Imaging for the Evaluation of Retinal Oedema And New vesseLs in Diabetic Retinopathy
Completed	`NCT01627977` - Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy	Phase 3
Completed	`NCT00776763` - Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab	Phase 2
Terminated	`NCT00563628` - Changes in Macular Thickness After Patterns Scan Laser	Phase 4
Terminated	`NCT00563043` - Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment	Phase 4
Completed	`NCT00682240` - Morphological and Functional Retinal Changes Following Retinal Photocoagulation	Phase 4
Completed	`NCT00446381` - Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)	N/A
Completed	`NCT02879422` - Genetic Markers and Proliferative Diabetic Retinopathy	N/A
Enrolling by invitation	`NCT02911311` - Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy	N/A
Recruiting	`NCT05514925` - Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy	Phase 4
Completed	`NCT02858076` - Anti-VEGF vs. Prompt Vitrectomy for VH From PDR	Phase 2/Phase 3

NCT number	NCT03633266
Study type	Interventional
Source	Wenzhou Medical University
Contact	Yong Wei, M.D
Phone	+86 15057551266
Email	weiyongdoctor@163.com
Status	Not yet recruiting
Phase	N/A
Start date	September 1, 2018
Completion date	December 1, 2022

Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms